News

Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...
A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.
Deutsche Bank AG boosted its stake in Regeneron Pharmaceuticals by nearly 22% in Q4, now holding 539,269 shares valued at ...
We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst ...
With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have ...
Fintel reports that on May 7, 2025, Leerink Partners upgraded their outlook for Amylyx Pharmaceuticals (NasdaqGS:AMLX) from Market Perform to Outperform. Analyst Price Forecast Suggests 93.03% ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Fintel reports that on May 7, 2025, Leerink Partners upgraded their outlook for Amylyx Pharmaceuticals (NasdaqGS:AMLX) from Market Perform to Outperform. As of May 7, 2025, the average one-year ...